ABEONA THERAPEUTICS INC. Interest Payable, Current
ABEONA THERAPEUTICS INC. (ABEO) had Interest Payable, Current of $0 as of 2012-12-31, per its 10-K filed 2013-03-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2014-03-26
- 2012-12-31: Interest Payable, Current $0.00.
- 2012-09-30: Interest Payable, Current $19.00K.
- 2012-09-13: Interest Payable, Current $330.00K.
- 2012-06-30: Interest Payable, Current $264.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-20 |
| 2012-09-30 | $19.00K 10-Q · filed 2012-11-14 |
| 2012-09-13 | $330.00K 10-K · filed 2014-03-26 |
| 2012-06-30 | $264.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $181.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $98.00K 10-K · filed 2013-03-20 |
| 2011-09-30 | $30.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $525.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $126.00K 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |